✦ LIBER ✦

Prevention of renal function worsening after percutaneous coronary interventions by hemofiltration in patients at high risk for contrast nephropathy

✍ Scribed by Giancarlo Marenzi; Gianfranco Lauri; Emilio Assanelli; Marco Grazi; Jeness Campodonico; Ivana Marana; Daniela Trabattoni; Antonio L. Bartorelli

Book ID: 119543561
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 146 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80000-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S18-YIA-3 RISK FACTORS AND CLINICAL OUTC

S18-YIA-3 RISK FACTORS AND CLINICAL OUTCOMES FOR CONTRAST INDUCED NEPHROPATHY POST PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH NORMAL BASELINE RENAL FUNCTION

✍ Eric Chong; Liang Shen; Yiong H. Chan; Huay C. Tan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

TCT-147 High dose Atorvastatin Pretreatm

TCT-147 High dose Atorvastatin Pretreatment for Preventing Contrast-Induced Nephropathy in Patients Receiving Primary Percutaneous Coronary Intervention: Prespecified Substudy of a Prospective Randomized Clinical trial

✍ Sang-Ho Jo; Hyun-Sook Kim; Jin-Ho Choi; Seung-Hyuk Choi; Joo-Yong Hahn; Sung Yun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Short-Term, High-Dose Atorvastatin Pretr

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB